Call Buying Activity in Elanco Animal Health (ELAN) Targets Upside in Shares Through March -Susquehanna
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
UPDATE: Credit Suisse Upgrades Elanco Animal Health (ELAN) to Outperform
February 26, 2021 4:39 AM EST(Updated - February 26, 2021 5:27 AM EST)
Credit Suisse analyst Erin Wilson Wirght upgraded Elanco Animal Health (NYSE: ELAN) from Neutral to Outperform with a price target of $38.00 (from $33.00).
The analyst comments "e are upgrading Elanco (ELAN) to Outperform (from Neutral) on incremental... More
Elanco Animal Health (ELAN) Tops Q4 EPS by 3c, Offers Guidance
February 24, 2021 6:40 AM ESTElanco Animal Health (NYSE: ELAN) reported Q4 EPS of $0.12, $0.03 better than the analyst estimate of $0.09. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.06 billion.
GUIDANCE:
Elanco Animal Health sees Q1 2021 EPS of $0.20-$0.25, versus the... More
